Discovery and characterization of selective small molecule inhibitors of the mammalian mitochondrial division dynamin, DRP1

被引:23
|
作者
Mallat, A. [1 ]
Uchiyama, L. F. [2 ]
Lewis, S. C. [2 ]
Fredenburg, R. A. [1 ]
Terada, Y. [3 ]
Ji, N. [1 ]
Nunnari, J. [2 ]
Tseng, C. C. [1 ]
机构
[1] Mitobridge Inc, Cambridge, MA 02138 USA
[2] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA
[3] Astellas Pharma Inc, Drug Discovery Res, Tsukuba, Ibaraki, Japan
关键词
DRP1; Mitochondria; Small molecule inhibitor; Fission; Dynamics; FISSION; FUSION; NEURODEGENERATION; PROTEIN-1; PROTECTS;
D O I
10.1016/j.bbrc.2018.03.189
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Balanced rates of mitochondrial division and fusion are required to maintain mitochondrial function, as well as cellular and organismal homeostasis. In mammals, the cellular machines that mediate these processes are dynamin-related GTPases; the cytosolic DRP1 mediates division, while the outer membrane MFN1/2 and inner membrane OPA1 mediate fusion. Unbalanced mitochondrial dynamics are linked to varied pathologies, including cell death and neurodegeneration, raising the possibility that small molecules that target the division and fusion machines to restore balance may have therapeutic potential. Here we describe the discovery of novel small molecules that directly and selectively inhibit assembly-stimulated GTPase activity of the division dynamin, DRP1. In addition, these small molecules restore wild type mtDNA copy number in MFN1 knockout mouse embryonic fibroblast cells, a phenotype linked to deficient mitochondrial fusion activity. Thus, these compounds are unique tools to explore the roles of mitochondrial division in cells, and to assess the potential therapeutic efficacy of rebalancing mitochondrial dynamics in pathologies associated with excessive mitochondrial division. (C) 2018 Elsevier Inc. All rights reserved.
引用
收藏
页码:556 / 562
页数:7
相关论文
共 34 条
  • [31] Dynamin-Related Protein 1 (DRP1)-Mediated Mitochondrial Fission Promotes Smooth Muscle Cell Hyperproliferation in Human and Experimental Pulmonary Hypertension Which Can be Therapeutically Targeted by the Fission Inhibitor MDIVI-1
    Marsboom, Glenn
    Toth, Peter T.
    Hong, Zhigang
    Wu, Xichen
    Fang, Yong-Hu
    Thenappan, Thenappan
    Zhang, Hannah J.
    Bache-Wiig, Peter
    Pogoriler, Jennifer
    Chen, Yimei
    Weir, E. Kenneth
    Rehman, Jalees
    Archer, Stephen L.
    CIRCULATION, 2011, 124 (21)
  • [32] In silico identification and characterization of small-molecule inhibitors specific to RhoG/Rac1 signaling pathway
    Dipankar, Pankaj
    Kumar, Puneet
    Sarangi, Pranita P.
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2023, 41 (02) : 560 - 580
  • [33] A Novel Time-Resolved Fluorescence Resonance Energy Transfer Assay for the Discovery of Small-Molecule Inhibitors of HIV-1 Tat-Regulated Transcription
    Shin, Young Hyun
    Kim, Dong-Eun
    Yu, Kyung Lee
    Park, Chul Min
    Kim, Hong Gi
    Kim, Kyung-Chang
    Bae, Songmee
    Yoon, Cheol-Hee
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (11)
  • [34] Discovery, Structure-Activity Relationship and In Vitro Anticancer Activity of Small-Molecule Inhibitors of the Protein-Protein Interactions between AF9/ENL and AF4 or DOT1L
    Li, Xin
    Wu, Xiaowei
    Nie, Shenyou
    Zhao, Jidong
    Yao, Yuan
    Wu, Fangrui
    Mishra, Chandra Bhushan
    Ashraf-Uz-Zaman, Md
    Moku, Bala Krishna
    Song, Yongcheng
    CANCERS, 2023, 15 (21)